Novo Nordisk Ozempic Pen

News

Novo Nordisk, Drugmaker and 2025 sales

Novo Nordisk names new CEO amid share price slump and concerns over Wegovy, Ozempic sales

The announcement came amid a slump in the company's share price and investor concerns about its experimental drug pipeline and ability to navigate challenges in the US market.

NPR · 31m

Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to stop them.

Reuters · 9h

Obesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook

Obesity drugmaker Novo Nordisk warned on Tuesday that full-year sales and operating profit would grow less than previously expected, marking its second forecast cut of 2025.

6hon MSN

Ozempic maker Novo Nordisk on track for its worst day since Black Monday

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

UNILAD1d

Study reveals what happens to your body after you stop taking weight loss drugs

New research has revealed that people taking weight loss drugs like Wegovy and Mounjaro are increasingly more likely to ...

The Motley Fool1mon

How to Buy Ozempic Stock | The Motley Fool

Ozempic, a type 2 diabetes treatment, presents investment opportunities via Novo Nordisk stock. Projected GLP-1 market growth to almost $160 billion by early the 2030s indicates long-term sector ...

Wall Street Journal1y

Novo Nordisk Tops $500 Billion Valuation; Ozempic, Wegovy Fuel Earnings

Ozempic pens being assembled at the Novo Nordisk factory in Hillerod, Denmark. (Charlotte de la Fuente for The Wall Street Journal) Shares of Europe's most valuable company rallied around 3.6% ...

9hon MSN

Weight-loss drug boom likely to fuel an injector pen maker

As weight-loss drug sales surge with semaglutide's patent expiration, Gujarat's Shaily Engineering Plastics, an injector pen ...

New Atlas1mon

Novo Nordisk unveils new weight loss drugs strategy

Weight loss therapeutics is a lucrative market and one that has now landed Novo Nordisk DKK65.1 billion, or more than US$10 billion, in profits – with nearly half of this from 2024 alone.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results